Prophylactic Tranexamic Acid Use After Vaginal Delivery
Condition(s):Postpartum Hemorrhage; Vaginal Delivery; Prophylactic Tranexamic Acid UseLast Updated:June 23, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Postpartum Hemorrhage; Vaginal Delivery; Prophylactic Tranexamic Acid UseLast Updated:June 23, 2022Completed
Condition(s):Hemorrhage From Placenta Previa, With DeliveryLast Updated:January 12, 2021Recruiting
Condition(s):Abortion; Dilation and Evacuation; Hemorrhage; Blood LossLast Updated:May 26, 2022Recruiting
Condition(s):Fibroid Uterus; Abnormal Uterine Bleeding; Myoma;UterusLast Updated:April 11, 2022Recruiting
Condition(s):Bleeding ReductionLast Updated:August 30, 2017Unknown status
Condition(s):Postpartum HemorrhageLast Updated:October 27, 2020Terminated
Condition(s):Hematologic NeoplasmsLast Updated:July 1, 2022Recruiting
Condition(s):Hematologic NeoplasmsLast Updated:May 18, 2020Completed
Condition(s):Hemorrhage of Cesarean Section and/or Perineal Wound; Postpartum Hemorrhage; Uterine AtonyLast Updated:September 5, 2016Completed
Condition(s):Hemorrhage of Cesarean Section and/or Perineal Wound; Postpartum HemorrhageLast Updated:June 15, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.